HomeCompareCSAMF vs JEPQ

CSAMF vs JEPQ: Dividend Comparison 2026

CSAMF yields 9.90% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CSAMF wins by $407896.07M in total portfolio value
10 years
CSAMF
CSAMF
● Live price
9.90%
Share price
$4.82
Annual div
$0.48
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$407896.11M
Annual income
$400,131,239,290.63
Full CSAMF calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — CSAMF vs JEPQ

📍 CSAMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCSAMFJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CSAMF + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CSAMF pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CSAMF
Annual income on $10K today (after 15% tax)
$841.44/yr
After 10yr DRIP, annual income (after tax)
$340,111,553,397.04/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, CSAMF beats the other by $340,111,551,567.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CSAMF + JEPQ for your $10,000?

CSAMF: 50%JEPQ: 50%
100% JEPQ50/50100% CSAMF
Portfolio after 10yr
$203948.08M
Annual income
$200,065,620,721.61/yr
Blended yield
98.10%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CSAMF buys
0
JEPQ buys
0
No recent congressional trades found for CSAMF or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCSAMFJEPQ
Forward yield9.90%11.10%
Annual dividend / share$0.48$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%0%
Portfolio after 10y$407896.11M$44.8K
Annual income after 10y$400,131,239,290.63$2,152.59
Total dividends collected$407370.38M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: CSAMF vs JEPQ ($10,000, DRIP)

YearCSAMF PortfolioCSAMF Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$12,680$1,979.87$11,930$1,110.39+$750.00CSAMF
2$18,260$4,692.42$14,133$1,224.34+$4.1KCSAMF
3$32,169$12,630.66$16,632$1,340.46+$15.5KCSAMF
4$76,012$41,591.87$19,454$1,457.97+$56.6KCSAMF
5$265,032$183,698.34$22,626$1,576.08+$242.4KCSAMF
6$1,480,778$1,197,194.33$26,175$1,694.09+$1.45MCSAMF
7$14,087,114$12,502,681.79$30,133$1,811.32+$14.06MCSAMF
8$237,394,699$222,321,486.64$34,531$1,927.17+$237.36MCSAMF
9$7,256,891,462$7,002,879,134.27$39,403$2,041.08+$7256.85MCSAMF
10$407,896,113,155$400,131,239,290.63$44,787$2,152.59+$407896.07MCSAMF

CSAMF vs JEPQ: Complete Analysis 2026

CSAMFStock

CSAM Health Group AS provides various ehealth solutions in Norway and internationally. The company offers CSAM Arcidis, an integrated system for teleradiology; CSAM DICOM Server for handling radiology data; CSAM HelseMail for transfer of confidential patient data between healthcare organizations; CSAM Infobroker, a vendor-neutral telemedicine system for radiology that enables multiple clinicians to share resources and knowledge; CSAM S7, a platform for self-care and health counselling; CSAM Web Client, a web-based user interface and connectivity solution that allows users to access multiple CSAM applications and functions; and CSAM XDS, a central archive for storing and managing various types of clinical patient data. It also provides CSAM Cardio, an ECG and diagnostic storage tool; CSAM CIMA, a mobile application for capturing, using, and sending medical media; CSAM Media, a web-based medical imaging solution; CSAM Medimaker for image management and workflow solution; CSAM Picsara, an image management solution; and CSAM TRIS, a radiology information system. In addition, the company offers CSAM Partus, a maternity information system; CSAM Natus, a maternity care system; CSAM iPana Labor Information System, a web-based labour information system; CSAM iPana Maternity, a cloud-based service platform that enables expectant mothers, hospitals, and maternity clinics to electronically collect, store, and share medical information; and CSAM Fertsoft, a care and practice management software. Further, it provides CSAM Optima Predict solution for operational planning; CSAM Optima Live; CSAM AMIS, an emergency medical information system; CSAM IMTS, a tool for assessing and prioritizing patients; CSAM Paratus, an emergency response system; CSAM CoordCom; CSAM ResQMobile; CSAM Cytodose, an oncology management solution; and CSAM ProSang, an advanced laboratory information management system. The company was founded in 1999 and is headquartered in Oslo, Norway.

Full CSAMF Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this CSAMF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CSAMF vs SCHDCSAMF vs JEPICSAMF vs OCSAMF vs KOCSAMF vs MAINCSAMF vs XYLDCSAMF vs QYLDCSAMF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.